160 related articles for article (PubMed ID: 25995358)
1. Bone Morphogenetic Protein 4 and Smad1 Mediate Extracellular Matrix Production in the Development of Diabetic Nephropathy.
Matsubara T; Araki M; Abe H; Ueda O; Jishage K; Mima A; Goto C; Tominaga T; Kinosaki M; Kishi S; Nagai K; Iehara N; Fukushima N; Kita T; Arai H; Doi T
Diabetes; 2015 Aug; 64(8):2978-90. PubMed ID: 25995358
[TBL] [Abstract][Full Text] [Related]
2. The role of the BMP4/Smad1 signaling pathway in mesangial cell proliferation: A possible mechanism of diabetic nephropathy.
Chen C; Lin J; Li L; Zhu T; Gao L; Wu W; Liu Q; Ou S
Life Sci; 2019 Mar; 220():106-116. PubMed ID: 30708099
[TBL] [Abstract][Full Text] [Related]
3. Activation of bone morphogenetic protein 4 signaling leads to glomerulosclerosis that mimics diabetic nephropathy.
Tominaga T; Abe H; Ueda O; Goto C; Nakahara K; Murakami T; Matsubara T; Mima A; Nagai K; Araoka T; Kishi S; Fukushima N; Jishage K; Doi T
J Biol Chem; 2011 Jun; 286(22):20109-16. PubMed ID: 21471216
[TBL] [Abstract][Full Text] [Related]
4. All-trans retinoic acid suppresses bone morphogenetic protein 4 in mouse diabetic nephropathy through a unique retinoic acid response element.
Tamaki M; Tominaga T; Fujita Y; Koezuka Y; Ichien G; Murakami T; Kishi S; Yamamoto K; Abe H; Nagai K; Doi T
Am J Physiol Endocrinol Metab; 2019 Mar; 316(3):E418-E431. PubMed ID: 30601699
[TBL] [Abstract][Full Text] [Related]
5. Expression of Smad1 is directly associated with mesangial matrix expansion in rat diabetic nephropathy.
Matsubara T; Abe H; Arai H; Nagai K; Mima A; Kanamori H; Sumi E; Takahashi T; Matsuura M; Iehara N; Fukatsu A; Kita T; Doi T
Lab Invest; 2006 Apr; 86(4):357-68. PubMed ID: 16482100
[TBL] [Abstract][Full Text] [Related]
6. Urinary Smad1 is a novel marker to predict later onset of mesangial matrix expansion in diabetic nephropathy.
Mima A; Arai H; Matsubara T; Abe H; Nagai K; Tamura Y; Torikoshi K; Araki M; Kanamori H; Takahashi T; Tominaga T; Matsuura M; Iehara N; Fukatsu A; Kita T; Doi T
Diabetes; 2008 Jun; 57(6):1712-22. PubMed ID: 18285555
[TBL] [Abstract][Full Text] [Related]
7. SOX9 protein induces a chondrogenic phenotype of mesangial cells and contributes to advanced diabetic nephropathy.
Kishi S; Abe H; Akiyama H; Tominaga T; Murakami T; Mima A; Nagai K; Kishi F; Matsuura M; Matsubara T; Iehara N; Ueda O; Fukushima N; Jishage K; Doi T
J Biol Chem; 2011 Sep; 286(37):32162-9. PubMed ID: 21795715
[TBL] [Abstract][Full Text] [Related]
8. Camel milk attenuates the biochemical and morphological features of diabetic nephropathy: inhibition of Smad1 and collagen type IV synthesis.
Korish AA; Abdel Gader AG; Korashy HM; Al-Drees AM; Alhaider AA; Arafah MM
Chem Biol Interact; 2015 Mar; 229():100-8. PubMed ID: 25617480
[TBL] [Abstract][Full Text] [Related]
9. Scleraxis modulates bone morphogenetic protein 4 (BMP4)-Smad1 protein-smooth muscle α-actin (SMA) signal transduction in diabetic nephropathy.
Abe H; Tominaga T; Matsubara T; Abe N; Kishi S; Nagai K; Murakami T; Araoka T; Doi T
J Biol Chem; 2012 Jun; 287(24):20430-42. PubMed ID: 22474292
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II-dependent Src and Smad1 signaling pathway is crucial for the development of diabetic nephropathy.
Mima A; Matsubara T; Arai H; Abe H; Nagai K; Kanamori H; Sumi E; Takahashi T; Iehara N; Fukatsu A; Kita T; Doi T
Lab Invest; 2006 Sep; 86(9):927-39. PubMed ID: 16767106
[TBL] [Abstract][Full Text] [Related]
11. Novel Interplay Between Smad1 and Smad3 Phosphorylation via AGE Regulates the Progression of Diabetic Nephropathy.
Ono H; Abe H; Sakurai A; Ochi A; Tominaga T; Tamaki M; Kishi S; Murakami T; Nagai K; Kohashi M; Doi T
Sci Rep; 2018 Jul; 8(1):10548. PubMed ID: 30002389
[TBL] [Abstract][Full Text] [Related]
12. An adjustment in BMP4 function represents a treatment for diabetic nephropathy and podocyte injury.
Fujita Y; Tominaga T; Abe H; Kangawa Y; Fukushima N; Ueda O; Jishage KI; Kishi S; Murakami T; Saga Y; Kanwar YS; Nagai K; Doi T
Sci Rep; 2018 Aug; 8(1):13011. PubMed ID: 30158674
[TBL] [Abstract][Full Text] [Related]
13. [Recent progress in understanding the molecular pathogenesis of diabetic nephropathy].
Abe H
Rinsho Byori; 2011 Feb; 59(2):179-86. PubMed ID: 21476304
[TBL] [Abstract][Full Text] [Related]
14. Delivery of megsin siRNA plasmid reveals therapeutic potential against diabetic nephropathy by down-regulating p27(kip1) level.
Liu M; Zhang Y; Chi Y; Zhai S; Wang B; Shi Y; Li Y
J Nephrol; 2012; 25(3):418-25. PubMed ID: 21928229
[TBL] [Abstract][Full Text] [Related]
15. The current clinical problems for early phase of diabetic nephropathy and approach for pathogenesis of diabetic nephropathy.
Doi T; Mima A; Matsubara T; Tominaga T; Arai H; Abe H
Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S21-4. PubMed ID: 18842318
[TBL] [Abstract][Full Text] [Related]
16. Role of Smad1 in diabetic nephropathy: Molecular mechanisms and implications as a diagnostic marker.
Abe H; Matsubara T; Arai H; Doi T
Histol Histopathol; 2011 Apr; 26(4):531-41. PubMed ID: 21360446
[TBL] [Abstract][Full Text] [Related]
17. Transcription factor 7-like 2 (TCF7L2) regulates activin receptor-like kinase 1 (ALK1)/Smad1 pathway for development of diabetic nephropathy.
Araoka T; Abe H; Tominaga T; Mima A; Matsubara T; Murakami T; Kishi S; Nagai K; Doi T
Mol Cells; 2010 Sep; 30(3):209-18. PubMed ID: 20803090
[TBL] [Abstract][Full Text] [Related]
18. Deficiency of cannabinoid receptor of type 2 worsens renal functional and structural abnormalities in streptozotocin-induced diabetic mice.
Barutta F; Grimaldi S; Franco I; Bellini S; Gambino R; Pinach S; Corbelli A; Bruno G; Rastaldi MP; Aveta T; Hirsch E; Di Marzo V; Gruden G
Kidney Int; 2014 Nov; 86(5):979-90. PubMed ID: 24827776
[TBL] [Abstract][Full Text] [Related]
19. Suppressions of chronic glomerular injuries and TGF-beta 1 production by HGF in attenuation of murine diabetic nephropathy.
Mizuno S; Nakamura T
Am J Physiol Renal Physiol; 2004 Jan; 286(1):F134-43. PubMed ID: 14519594
[TBL] [Abstract][Full Text] [Related]
20. Renal synthesis of urokinase type-plasminogen activator, its receptor, and plasminogen activator inhibitor-1 in diabetic nephropathy in rats: modulation by angiotensin-converting-enzyme inhibitor.
Kenichi M; Masanobu M; Takehiko K; Shoko T; Akira F; Katsushige A; Takashi H; Yoshiyuki O; Shigeru K
J Lab Clin Med; 2004 Aug; 144(2):69-77. PubMed ID: 15322501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
